A detailed history of Charles Schwab Investment Management Inc transactions in Prime Medicine, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 297,823 shares of PRME stock, worth $1.59 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
297,823
Previous 296,188 0.55%
Holding current value
$1.59 Million
Previous $2.62 Million 20.58%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

BUY
$6.35 - $9.39 $10,382 - $15,352
1,635 Added 0.55%
297,823 $2.08 Million
Q4 2023

Feb 06, 2024

BUY
$5.59 - $9.55 $20,224 - $34,551
3,618 Added 1.24%
296,188 $2.62 Million
Q3 2023

Nov 08, 2023

BUY
$9.5 - $15.07 $1.44 Million - $2.28 Million
151,426 Added 107.28%
292,570 $2.79 Million
Q2 2023

Aug 09, 2023

BUY
$11.41 - $17.05 $772,650 - $1.15 Million
67,717 Added 92.22%
141,144 $2.07 Million
Q1 2023

May 11, 2023

BUY
$11.21 - $21.11 $25,144 - $47,349
2,243 Added 3.15%
73,427 $903,000
Q4 2022

Feb 13, 2023

BUY
$16.24 - $21.12 $1.16 Million - $1.5 Million
71,184 New
71,184 $1.32 Million

Others Institutions Holding PRME

About Prime Medicine, Inc.


  • Ticker PRME
  • Shares Outstandng 95,730,200
  • Market Cap $511M
More about PRME
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.